Exposure of Siberian hamsters to short photoperiod for 14wks induces ovarian regression. Subsequent transfer to long photoperiod restores ovarian function, and 2 weeks of photostimulation increases plasma estradiol, antral follicles and corpora lutea. Because tissue remodeling involved with photostimulated ovarian recrudescence is associated with differential expression of matrix metalloproteinases (MMPs), we hypothesized that inhibiting MMP activity using a broad-spectrum in vivo MMP-inhibitor, GM6001, would curtail recrudescence. One group of hamsters was placed in long-days (LD;16:8) for 16wks. Another group was placed in inhibitory short-days (SD;8:16) for 14wks. A third group was placed in SD for 14wks and transferred to LD for 2wks to stimulate recrudescence. During weeks 14–16 animals were either not treated, or treated daily with intraperitoneal injections of GM6001(20mg/kg), or vehicle(DMSO). GM6001 reduced gelatinase activity and decreased immunohistochemical staining for MMPs-1, -2 and -3 compared to vehicle. No differences between controls, vehicle, or GM6001 treatment were observed among LD animals, despite a trend towards reduction in corpora lutea and estradiol with GM6001. Whereas SD reduced ovarian function, photostimulation of transferred controls increased uterine mass, plasma estradiol, appearance of antral follicles and corpora lutea. With GM6001 treatment, photostimulation failed to increase uterine mass, plasma estradiol, antral follicles or corpora lutea. These data show, for the first time, that in vivo GM6001 administration inhibits MMP activity in hamster ovaries during photostimulation, and indicate that this inhibition may impede photostimulated recrudescence of ovaries. This study suggests an intriguing link between MMP activity and return to ovarian function during photostimulated recrudescence.